A combined risk model for the multi-encompassing identification of heterogeneities of prognoses, biological pathway variations and immune states for sepsis patients

Table 2 The therapeutic recommendations for patients with high risk score

Models	Therapeutic measures for patients with high risk score	Number of features
Molecule-risk	Be diverted to intensive care unit for maximal intervention	8
Pathway-risk	1.To improve oxygen delivery and decrease oxygen consumption; 2. More hemodynamic measurement to guide therapy.	9
Immunity-risk	1. To promote immunity therapy such as interferon and thymosin; 2. To be on guard against superinfection occurring.	4

In Table 2, we provided the therapeutic recommendations for patients with high risk score identified by three sub-models. In addition, the numbers of features in each sub-model were also shown in Table 2

ISSN: 1471-2253